Portfolio Lab

Amgen Inc

  • Stock
  • Ticker AMGN
  • ISIN US0311621009
  • Nasdaq

Health care · Biotechnology · USA

$435.64 −0.72%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Amgen Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

AMGNGlobal equities (VT)

$10,000 grew to $40,267. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −24.9% in 06/2023, measured from the peak in 11/2022. It took 11 months to get back to the old peak.

1-year return
+34.0%
5-year return p.a.
+19.8%
10-year return p.a.
+14.9%
Volatility p.a.
23.8%
Largest decline
−24.9%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue9,0868,1499,1799,5579,8668,61810,05410,365
Gross profit5,9745,1816,1686,4756,8905,8747,2437,577
Operating income2,3111,1782,6562,5262,7202,6663,5143,710
EBITDA3,7082,5652,8762,7583,8523,7823,7363,943
Net income6271,7301,4323,2161,3331,8192,3753,864
Earnings per share1.163.202.655.932.463.344.377.08
Balance sheet
Total assets91,83989,36787,89790,14190,58692,50495,63996,048
Liabilities85,96283,16080,46980,52281,92883,31483,95181,696
Equity5,8776,2077,4289,6198,6589,19011,68814,352
Cash11,9738,8108,0289,4459,12912,03813,98913,190
Long-term debt56,54954,01353,76052,43450,00551,88651,85951,609
Cash flow
Operating cash flow4,7711,3912,2804,6841,6032,1894,0024,241
Capital expenditure-371-411-369-436-642-712-513-587
Free cash flow4,4009801,9114,2489611,4773,4893,654

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2025 at +29.7%, weakest 2024 at −6.8%. 7 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
4 Nov 2026$7.08
5 Aug 2026$4.37
1 May 2026$3.34
13 Feb 2026$2.46
5 Nov 2025$5.93
6 Aug 2025$2.65
2 May 2025$3.20
14 Feb 2025$1.16
31 Oct 2024$5.22
7 Aug 2024$1.38
3 May 2024−$0.21
14 Feb 2024$1.43

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€214bn
Market cap in trading currency
$236bn
Enterprise value
$276bn
P/E
25.3
P/S
6.06
P/B
16.42
EV/Sales
7.11
EV/EBITDA
18.1
Earnings yield
4.0%
FCF yield
4.1%

Results (last four quarters)

Revenue
$38.9bn
Gross profit
$27.6bn
EBITDA
$15.3bn
Net income
$9.39bn
Earnings per share
$17.25
Revenue per share
$71.92
Revenue growth
+8.5%
Earnings growth
+20.1%

Profitability

Gross margin
70.9%
Operating margin
32.4%
Net margin
24.1%
Return on equity
78.4%
Return on assets
9.8%

Balance sheet and cash flow

Cash
$13.2bn
Cash per share
$24.38
Financial debt
$54.0bn
Debt/equity %
376
Current ratio
1.48
Book value per share
$26.53
Operating cash flow
$12.0bn
Free cash flow
$9.58bn

Dividend

Dividend yield
2.28%
Dividend (12 months)
$9.94
Yield (12 months)
2.28%
Payout ratio
58%
Ex-dividend date
21 Aug 2026

Shares and trading

Shares outstanding
541m
Volume
4.90m
Avg. volume 3 months
2.80m
Relative volume
1.8

Price and technicals

Price
$435.64
1 day
−0.7%
52-week high
$478.48
52-week low
$313.85
Distance to 52-week high
−9.0%
Distance to 52-week low
+38.8%
Distance to 50-day line
+1.2%
Distance to 200-day line
+13.6%
RSI (14)
41
Volatility 1M
26.3%

Performance

1 week
−6.4%
1 month
−2.6%
3 months
−1.8%
6 months
+28.4%
YTD
+33.1%
1 year
+27.2%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has AMGN performed since 11/2016?

$10,000 grew to $40,267 by 20 Nov 2026, which is +15.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is AMGN?

Volatility was 23.8% per year, measured on monthly returns. The largest decline from a peak was −24.9%, with the low in 06/2023.

How does AMGN compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, AMGN returned +15.0% at 23.8%. The correlation of monthly returns was 0.34; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Amgen Inc (AMGN): Return and risk | Portfolio Lab